B. Nilsson

发表

Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation

T. Tötterman, A. Zander, P. Hokland, 2000, Bone Marrow Transplantation.

More efficient mobilisation of peripheral blood stem cells with HiDAC+AMSA+G-CSF than with mini-ICE+G-CSF in patients with AML

M. Höglund, M. Hedenus, B. Simonsson, 2003, Bone Marrow Transplantation.

Treatment of minimal residual disease in myeloid leukemia--the immunotherapeutic options with emphasis on Linomide.

B. Simonsson, J. Rowe, B. Nilsson, 1993, Leukemia & lymphoma.

Use of Roquinimex in the Myeloid Leukemias

J. Rowe, B. Simonsson, B. Nilsson, 1996 .

Allografting in chronic myelogenous leukemia followed by immunotherapy

J. Liesveld, B. Simonsson, J. Rowe, 1993, Stem cells.

High doses of natural α‐interferon (α‐IFN) in the treatment of multiple myeloma — A pilot study from the Myeloma Group of Central Sweden (MGCS)

G. Gahrton, G. Juliusson, M. Björkholm, 1988 .

Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex

B. Simonsson, J. Rowe, C. Packman, 1999, Bone Marrow Transplantation.

Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia.

B. Simonsson, B. Smedmyr, M. Bengtsson, 1992, Transplantation.